Skip to main content

Peer Review reports

From: Real-world data on neoadjuvant chemotherapy with dual-anti HER2 therapy in HER2 positive breast cancer

Original Submission
22 Jun 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
10 Oct 2023 Reviewed Reviewer Report
23 Oct 2023 Reviewed Reviewer Report - Tatsunori Shimoi
24 Nov 2023 Author responded Author comments - Xu-Chen Cao
Resubmission - Version 3
24 Nov 2023 Submitted Manuscript version 3
11 Jan 2024 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
12 Jan 2024 Editorially accepted
25 Jan 2024 Article published 10.1186/s12885-024-11871-0

You can find further information about peer review here.

Back to article page